Month: March 2022

Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that …

Schizophrenia is a chronic psychiatric disorder. It affects how a person behaves, thinks, feels, and interacts with the world and the people around them. Symptoms first appear in a person’s...

Almost all family intervention models can prevent relapse in schizophrenia, according to a systematic review and meta-analysis published in the March issue of The Lancet Psychiatry.

Karuna Therapeutics is set to withdraw previous guidance for reporting topline data from its Phase III trial of KarXT to treat schizophrenia.